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Abstract  19 
 20 
The antimicrobial effects of red wine and its inherent components on oral microbiota have 21 
been studied by using a 5-species biofilm model of the supragingival plaque that includes 22 
Actinomyces oris, Fusobacterium nucleatum, Streptococcus oralis, Streptococcus mutans and 23 
Veillonella dispar.  24 
Microbiological analysis (CFU counting and confocal laser scanning microscopy) of the 25 
biofilms after the application of different test solutions (red wine, dealcoholized wine, red wine 26 
extract, grape seed extract and inactive dry yeast extracts) showed that the grape seed extract 27 
solution was the most effective, exhibiting high activity against F. nucleatum, S. oralis and A. 28 
oris. Additionally, both red wine and dealcoholized red wine had an antimicrobial effect 29 
against F. nucleatum and S. oralis. 30 
Additional experiments were carried out to determine any possible phenolic metabolism during 31 
formation of the bacterial biofilm. Flavan-3-ol precursors such as (+)-catechin and procyanidin 32 
B2 suffered an almost complete and early degradation when incubating biofilms with the red 33 
wine extract but no degradation was observed after incubation with the grape seed extract, 34 
probably due both to its higher concentration and antimicrobial effects. To our knowledge, this 35 
is the first study of antimicrobial properties of wine in an oral biofilm model. 36 
 37 
 38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
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Introduction 46 
The oral cavity is an enormously complex habitat with several hundred commensal microbial 47 
species colonizing it, and furthermore it is unique in the human body in possessing non-48 
shedding surfaces, the teeth, allowing microorganisms to adhere to the surface of teeth for long 49 
periods of time, embedded in a self-produced matrix of extracellular polymeric substances 50 
(Abee et al., 2011), and thus leading to extensive biofilm formation, dental plaque (Marsh, 51 
2003), which is more resistant than planktonic cells to mechanical stress or antibiotic treatment 52 
(Roberts et al., 2010). The microorganisms of dental plaque live with one another in a 53 
commensal or mutualistic symbiotic relationship, allowing a mixture of aerobic and anaerobic 54 
bacteria to live in the same environment. Some of these oral bacteria such as streptococci or 55 
lactobacilli are able to produce high levels of organic acids following fermentation of dietary 56 
sugars. Acids released from dental plaque lead to demineralization of the tooth surface and 57 
consequently to dental caries, periodontal disease or tooth loss (Hardie, 1992), which are the 58 
most prevalent oral diseases in humans, affecting up to 60–90% of the world population (da 59 
Silva et al., 2013).  60 
Even using mechanical removal, dental biofilms cannot be eliminated completely. 61 
Antimicrobial agents are complementarily used to control dental plaque (Furiga et al., 2008; 62 
Marsh et al., 2010; Kamonpatana et al., 2012). Until now, several substances have been tested 63 
for the control of oral biofilms, including essential oils, amine fluoride, triclosan, etc.,  but one 64 
of the most widely used and effective antibiofilm agents is chlorhexidine (Corbin et al., 2011). 65 
However, chlorhexidine has been associated with some secondary effects, namely the 66 
reduction of human taste perception and the pigmentation of oral tissues, which limits its 67 
application. Therefore, the search for new antimicrobials has arisen, and natural products are 68 
preferable due to the lack of secondary effects and therefore, the potential for long-term usage 69 
in the oral cavity.  70 
The inherent matrix of the biofilm, such as extracellular polymeric substances that reduce 71 
penetration of antimicrobial agents and the presence of persister cells surviving at low 72 
metabolic rates, contributes to the widely described phenomenon of reduced sensitivity to 73 
antimicrobial agents (Hoyle & Costerton, 1991). Because of this, biofilm models including 74 
bacteria and fungi from different species have proven both useful and reliable and reliability in 75 
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predicting in vivo efficacy of antimicrobials. In this sense, most experimental models for short-76 
term studies involve a solid surface for the adhesion of bacteria (Guggenheim et al., 2004).  77 
Although there is substantial literature reporting the antimicrobial properties of phenolic 78 
compounds or polyphenols against bacteria isolates (Jayaprakasha et al., 2003; Ozkan et al., 79 
2004; Cueva et al., 2010), information about their effect on oral pathogens is still scarce 80 
(Requena et al., 2010). Studies carried out with tea and cranberry polyphenols have shown an 81 
inhibitory effect on biofilm formation by oral pathogens such as Streptococcus mutans, 82 
Streptococcus oralis, Streptococcus sobrinus and Porphyromonas gingivalis (Bodet et al., 83 
2008). Grapes and wines are good dietary sources of polyphenolic compounds, including 84 
hydroxybenzoic and hydroxycinnamic acids, phenolic alcohols, flavan-3-ol monomers, 85 
oligomeric and polymeric procyanidins, flavonols, stilbenes and anthocyanins (only present in 86 
red varieties) (Monagas et al., 2003). Recently, it has been found that wine and grape phenolic 87 
extracts, as well as pomace phenolic extracts, were able to inhibit the growth of different 88 
Streptococcus spp. strains associated with dental caries (Thimothe et al., 2007; Furiga et al., 89 
2009).  90 
On the other hand, interactions between wine phenolics and oral microbiota can also include a 91 
possible bacterial catabolism of wine phenolics into less complex phenolic metabolite 92 
structures as seems to happen with flavonol glycosides (Requena et al., 2010). With regards to 93 
anthocyanins, their degradation in human saliva at 37 ºC has been described, being structure-94 
dependent, largely mediated by oral microbiota, and partially suppressed after oral rinsing with 95 
antibacterial chlorhexidine (Kamonpatana et al., 2012).  96 
With the final aim of seeking natural products that could be used in oral hygiene and to 97 
ascertain interactions between wine components and oral microbiota, in this study the 98 
antimicrobial effects of red wine and dealcoholized red wine were investigated using a biofilm 99 
model of the supragingival plaque that integrates five bacteria species commonly associated 100 
with oral disease. A wine phenolic extract (Provinols™), especially rich in anthocyanins, was 101 
also tested using the same model, and in both the absence and presence of other enological 102 
extracts from grape seeds (Vitaflavan®) and yeast (inactive dry yeast, IDY). Additional 103 
experiments were carried out to determine any possible phenolic metabolism during the 104 
formation of the bacterial biofilm.    105 
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 106 
Materials and methods 107 
Red wines 108 
The red wine used in this study was a young red wine (var. Pinot Noir, vintage 2010), kindly 109 
provided by Bodegas Miguel Torres S.A. (Catalonia, Spain). The wine was elaborated 110 
following the winery’s own winemaking procedures and was selected because of its relatively 111 
high phenolic content: total polyphenols = 1758 mg of gallic acid equivalents/L, total 112 
anthocyanins = 447 mg of malvidin-3-glucoside/L, and total catechins = 1612 mg of (+)-113 
catechin/L. Main individual phenolic compounds found in this wine included anthocyanins, 114 
flavan-3-ols, flavonols, alcohols, stilbenes and hydroxycinnamic acids (Muñoz-González et al., 115 
2013) (Table 1). 116 
For the preparation of dealcoholized red wine, ethanol was removed using a rotary evaporator 117 
and then distilled water was added until the original volume was reached. 118 
 119 
Enological extracts  120 
A wine extract, Provinols™, was kindly supplied by Safic-Alcan Especialidades S.A.U. 121 
(Barcelona, Spain). A grape seed extract, Vitaflavan® was kindly provided by Dr. Piriou (Les 122 
Dérivés Resiniques & Terpéniques S.A., France). The total phenolic content of the extracts was 123 
474 mg of gallic acid equivalents/g for Provinols™ and 629 mg of gallic acid equivalents/g for 124 
Vitaflavan®. The main phenolic compounds identified in both extracts are reported in Table 1. 125 
Also, two inactive dry yeast (IDY) commercial preparations (Saccharomyces cerevisiae), IDY 126 
1 and IDY 2, rich in mannoproteins, aminoacids and peptides, respectively, were kindly 127 
provided by Lallemand S.A. (Blagnac, France) and Agrovin S.A. (Alcázar de San Juan, Ciudad 128 
Real, Spain). 129 
The wine extract was dissolved in distilled water containing 2.5% DMSO (v/v), at a 130 
concentration of 1.6 g/L. The wine extract solution was fortified in grape seed polyphenols by 131 
adding 2.5 g of grape seed extract to 100 mL of the wine solution. Also, the wine extract 132 
solution was enriched in wine matrix components (mainly polysaccharides and nitrogen 133 
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compounds) by adding the IDY preparations to the wine extract solution at a final 134 
concentration of 0.4 g/L.  135 
 136 
Bacterial strains and culture (growth) conditions 137 
Actinomyces oris OMZ 745, Fusobacterium nucleatum OMZ 598, Streptococcus oralis OMZ 138 
607, Streptococcus mutans UA159 (OMZ 918) and Veillonella dispar ATCC 17748T (OMZ 139 
493) were obtained from the culture collection of the Institute of Oral Biology, University of 140 
Zürich. Prior to the experiment, pre-cultures were prepared by transferring the strains on 141 
Columbia Blood Agar plates and incubating them for 96 h at 37 ºC under anaerobic conditions. 142 
After this time, the strains were transferred from the Columbia Blood Agar plates to broth 143 
cultures (1 x 9 ml FUM in Sørensen’s buffer + 0.3 % glucose) (OMZ 493: + 1% sodium 144 
lactate) and incubated overnight at 37 ºC. After incubation, 200 µL of bacteria from each 145 
working culture were individually inoculated in 5 mL of fresh FUM media in Sørensen’s 146 
buffer and incubated at 37 ºC anaerobically (7 hours maximum). In order to obtain an 147 
inoculum containing cultures in the exponential growth phase of approximately 107 CFU/mL, a 148 
microbial suspension with equal volumes and densities of each strain was prepared. 149 
 150 
Saliva processing 151 
Saliva was collected and processed according to the protocol of Guggenheim et al. (2001). 152 
Briefly, whole unstimulated saliva was collected from volunteers for 1 h each morning, over 153 
several days, at least 1.5 h after eating, drinking, or teeth cleaning. Saliva samples were 154 
collected in sterile 50 mL polypropylene tubes, chilled in an ice bath or frozen at −20 °C. After 155 
500 mL saliva had been collected, it was pooled and centrifuged (30 min, 4 °C, 27,000 × g); 156 
the supernatant was pasteurized (60 °C, 30 min) and re-centrifuged in sterile tubes. The 157 
resulting supernatant was stored in sterile 50 mL polypropylene tubes at −80 °C. The 158 
efficiency of the process was assessed by plating the processed saliva samples onto CBA agar; 159 
after 72 h at 37 °C, no CFUs were observed on the incubated plates. A sterile 1:1 dilution in 160 
H2O+25% physiological NaCl was used for the biofilm formation and throughout the 161 
experimentation. 162 
 163 
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In vitro biofilm experiments 164 
Figure 1 shows a sequence chart regarding the biofilm formation prior to assays for 165 
determining changes in the microbial population of the biofilm and for assessing phenolic 166 
metabolism in the biofilm. 167 
 168 
Biofilm formation 169 
Biofilms were grown using the slightly modified protocol described by Guggenheim et al. 170 
(2001) and Thurnheer et al. (2006). In brief, the 5-species biofilms were grown in 24-well 171 
polystyrene cell-culture plates on hydroxyapatite (HA) discs of 9mm Ø (Clarkson 172 
Chromatography Products, South Williamsport, USA) previously preconditioned in 800 µL of 173 
whole unstimulated pooled saliva (as described in the previous section) during 4 h at room 174 
temperature, with shaking (95 rpm) in order to promote pellicle formation. To initiate the 175 
biofilm formation, the discs were covered for 45 minutes with 1.6 mL of a mixture comprising 176 
30% saliva, 70% modified fluid universal medium (mFUM) and 200 µL of the bacterial 177 
inoculum described above. mFUM corresponds to a well-established tryptone yeast-based 178 
broth medium designated as FUM (Gmür & Guggenheim, 1983) and modified by 179 
supplementing 67 m M Sørensen’s buffer (final pH 7.2). The carbohydrate concentration in 180 
mFUM was 0.3% (w/v) and consisted of glucose for the first 16 h and from then on of a 1:1 181 
(w/w) mixture of glucose and sucrose. 182 
After this first incubation, discs were subjected to three consecutive 1 min dip-washes in 2 ml 183 
0.9% NaCl to remove growth medium and free-floating cells but not microorganisms adhering 184 
firmly to the HA discs. Then, they were incubated anaerobically for 16.5 h at 37 °C in 185 
preconditioned and processed saliva to form the biofilm (Figure 1).  186 
 187 
Assay for determining changes in the microbial population of the biofilm  188 
Once the biofilm was formed, discs were maintained in a 24-well plate with preconditioned 189 
and processed saliva in anaerobic conditions for 7 days. Twice a day, and with 7 hours of 190 
difference in between, discs were “fed” by immersing them into a preconditioned fresh growth 191 
medium (30% saliva, 70% mFUM (v/v) containing 0.15% glucose and 0.15 % sucrose) for 45 192 
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minutes, at 37 ºC, under anaerobic conditions, After each “feeding”, discs were dipped in the 193 
different test solutions (1 mL) for 2 minutes and while being gently shaken by hand. After this 194 
time, the discs were dipped once in the preconditioned-processed saliva in order to clean any 195 
remains of the test solutions. Immediately after, discs were returned to the “old” 24-well plate 196 
with preconditioned and processed saliva and incubated anaerobically until the next “feeding” 197 
(Figure 1). After 7 days, biofilms were either stained for confocal laser scanning microscopy 198 
(see below) or harvested, at room temperature, in 1 mL of 0.9% NaCl by scratching with a 199 
special odontological instrument. Cell viability was tested using a Live/Dead BacLight 200 
Viability Kit (Molecular Probes Inc.) The total CFU, streptococci and all taxa were assessed by 201 
anaerobic culture (37 ºC) using selective (Mitis Salivarious for Streptococcus oralis and 202 
Streptococcus mutans; Fastidious Anaerobe Agar for Fusobacterium nucleatum) and non-203 
selective media (Columbia Blood Agar for Actinomyces oris, Veillonella dispar and total CFU) 204 
and colonies were counted.  205 
Distilled water was used as the negative antimicrobial control, and 0.2% chlorhexidine-206 
gluconate solution (Sigma-Aldrich, Steinheim, Germany) in water was the positive 207 
antimicrobial control. In order to discard a possible antimicrobial effect of the alcohol12% 208 
ethanol in water was also tested. For both, test solutions and controls, experiments were carried 209 
out in triplicate.  210 
 211 
Assay for assessing phenolic metabolism in the biofilm 212 
After initiating biofilm formation as described above, the 70:30 saliva:mFUM media was 213 
enriched with the wine extract (1.6 g/L) in the absence of the presence of grape seed extract 214 
(10 g/L) and added into the wells containing the discs (Figure 1). Then, plates were incubated 215 
at 37 ºC under anaerobic conditions and aliquots of enriched media were taken at 0, 2, 4, 6, 8 216 
and 24 hours. 217 
 218 
Analysis of wine compounds and bacterial/microbial metabolites 219 
Phenolic compounds were analyzed using an UPLC-ESI-MS/MS following a previously 220 
reported method (Muñoz-González et al., 2013). The liquid chromatographic system was a 221 
Waters Acquity UPLC (Milford, MA) equipped with a binary pump, an autosampler 222 
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thermostatted at 10 ºC, and a heated column compartment (40 ºC). The column employed was 223 
a BEH-C18, 2.1 x 100 mm and 1.7 µm particle size from Waters (Milford, MA). The mobile 224 
phases were 2% acetic acid in water (A) and 2% acetic acid in acetonitrile (B). The gradient 225 
program was as follows: 0 min, 0.1% B; 1.5 min, 0.1% B; 11.17 min, 16.3% B; 11.5 min, 226 
18.4% B; 14 min, 18.4% B; 14.1 min, 99.9% B; 15.5 min, 99.9% B; 15.6 min, 0.1% B. 227 
Equilibrium time was 2.4 min resulting in a total runtime of 18 min. The flow rate was set 228 
constant at 0.5 mL/min and injection volume was 2 µL. 229 
The LC effluent was pumped to an Acquity TQD tandem quadrupole mass spectrometer 230 
equipped with a Z-spray electrospray ionization (ESI) source operated in negative polarity 231 
mode. The ESI parameters were set as follows: capillary voltage, 3 kV; source temperature, 232 
130 ºC; desolvation temperature, 400 ºC; desolvation gas (N2) flow rate, 750 L/h; cone gas 233 
(N2) flow rate, 60 L/h. The ESI was operated in negative ionization mode. For quantification 234 
purposes, data were collected in the multiple reaction monitoring (MRM) mode, tracking the 235 
transition of parent and product ions specific to each compound. The MS/MS parameters (cone 236 
voltage, collision energy and MRM transition) of the 60 phenolic compounds targeted in the 237 
present study (mandelic acids, benzoic acids, phenols, hippuric acids, phenylacetic acids, 238 
phenylpropionic acids, cinnamic acids, 4-hydroxyvaleric acids and valerolactones) were 239 
previously reported (Jiménez-Girón et al., 2013). Data acquisition and processing was realized 240 
with MassLynx 4.1 software. 241 
 242 
Staining of biofilms and confocal laser scanning microscopy (CLSM) 243 
For CLSM, treated as well as untreated biofilms were stained using the LIVE/DEAD BacLight 244 
bacterial viability assay (Invitrogen, Zug, Switzerland) according to the instructions of the 245 
manufacturer. After 20 min staining, excess dye was gently aspirated from the discs without 246 
touching the biofilms. They were embedded upside-down in 20 µl of Mowiol (Thurnheer et al., 247 
2003) and stored at room temperature in the dark for at least 6 h prior to microscopic 248 
examination.  249 
Stained biofilms were examined by CLSM at randomly selected positions using a Leica TCS 250 
SP5 (Leica Microsystems, Heidelberg GmbH, Germany) with a x20/0.8 numerical aperture 251 
(NA) and x63/1.4 NA oil immersion objective lens in conjunction with 488-nm laser excitation 252 
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and 530-nm emission filters for Syto 9 (live stain), and 561-nm laser excitation and 640-nm 253 
emission filters for propidium iodide (dead stain). Image acquisition was done in 8-line 254 
average mode and the data were processed using Imaris 7.2.2 (Bitplane AG, Zurich, 255 
Switzerland). 256 
 257 
Statistical analysis 258 
Means and standard deviations were calculated using Microsoft Excel 2007. Statistical 259 
analyses were performed through Statistica©. To compare the antimicrobial effects of the 260 
different treatments with the control (water), the Dunnett test was applied. Graphs were 261 
performed with Microsoft Excel 2007. 262 
 263 
Results and discussion 264 
Antimicrobial properties of wine and dealcoholized red wine on the biofilm 265 
The effects of a red wine and the same wine without ethanol on a biofilm model comprised of 266 
five representative species commonly encountered in supragingival plaque, including Gram-267 
positive (A. oris, S. mutans, S. oralis) as well as Gram-negative (F. nucleatum, V. dispar) 268 
bacteria (Guggenheim et al., 2001), were investigated. Among these bacteria were the so-269 
called early colonizers, A. oris, S. oralis and V. dispar, and late colonizers, S. mutans and F. 270 
nucleatum, the latter also designated as a bridging organism due to its capability to co-271 
aggregate with a wide range of early and late colonizers (Kolenbrander et al., 2006). When 272 
discs were dipped into both red wine and dealcoholized red wine, some decrease in cell 273 
viability of the whole biofilm was visually estimated (Figure 2C) in comparison to the control 274 
(Figure 2A). CFU values for the five bacteria comprising the biofilm indicated an important 275 
reduction in F. nucleatum and S. oralis population when applying red wine and dealcoholized 276 
red wine to the biofilm, in comparison to the negative control (distilled water) (Table 2). The 277 
Dunnett test confirmed significant differences in the population of these two strains after the 278 
treatment with wine and dealcoholized wine. Generally, wines contain between 10–12% of 279 
ethanol, which have antimicrobial properties. To understand the action mechanism of red 280 
wines in more depth, the effects of ethanol of the bacteria biofilm were investigated.  The 281 
treatment with 12% ethanol resulted in a significant decrease in the population of F. nucleatum 282 
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(Table 2). However, since treatments of the biofilm with both wine and dealcoholized wine 283 
inhibited F. nucleatum growth, it was likely that other wine components – apart from ethanol – 284 
had antimicrobial properties against this bacteria species.  As expected, all the strains were 285 
eradicated after the treatment with the positive control (0.2% chlorexidine-gluconate solution) 286 
(Table 2). 287 
In an intervention study with 75 volunteers, Signoretto et al. (2010) analyzed the microbial 288 
population of supragingival and subgingival plaque using PCR-DGGE and found that F. 289 
nucleatum was less frequentl in wine drinkers compared with water drinkers. Other authors 290 
such as Daglia et al. (2007) have also shown antimicrobial properties of dealcoholized wine 291 
against oral streptococci. Both studies were consistent with our results in that wine selectively 292 
inhibited the growth of F. nucleatum and S. oralis in the presence of other species such as S. 293 
mutans, A. oris and V .dispar in an oral biofilm model.  294 
Given the antimicrobial effects of wine observed in the first experiment, the next step was to 295 
study the influence of some wine-specific components such as polyphenols, including flavan-296 
3-ols, peptides or yeast polysaccharides. For that purpose, a red wine extract solution spiked 297 
with different extracts rich in those specific components of wine (grape seed extract rich in 298 
flavan-3-ols, and two inactive dry yeasts rich in peptides and mannoproteins, respectively) 299 
were used. Table 3 reports the CFU values of the five bacteria species of the tested biofilm 300 
after treatments with wine extract and wine extract solution spiked with different extracts 301 
(grape seed extract, IDY1 and IDY2). Dunnett’s test showed significant differences in F. 302 
nucleatum, S. oralis and A. oris with the application of the wine extract spiked with the grape 303 
seed extract rich in flavan-3-ols (Monagas et al., 2003). However, wine extract solutions 304 
spiked with IDY1 and IDY2 did not show any effect in the populations of the five-strain 305 
biofilm. Notably, a great decrease in the viability of the cell was visually appreciated in the 306 
biofilm recovered from the discs that were dipped in the grape seed extract solution (Figure 307 
2D). Cueva et al. (2012) reported significant inhibition in the growth of some oral streptococci, 308 
such as Streptococcus mutans and Streptococcus sobrinus, when incubating planktonic cultures 309 
with flavan-3-ols precursors, (+)-catechin and (-)-epicatechin, in which grape seed extract is 310 
particularly rich. Moreover, they showed that extracts from grape seed, especially Vitaflavan® 311 
and its oligomeric fraction, exerted higher antimicrobial activity against various oral pathogens 312 
than the rest of the extracts tested (red wine extract and grape pomace extract). Similarly, 313 
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Rotava et al. (2009) and Baydar et al. (2006) reported antimicrobial effects of grape seed 314 
extracts against pathogenic bacteria such as S. aureus and E.coli. It has been suggested that the 315 
high concentration of flavonoids and their derivatives in grape seeds could be responsible of 316 
the antimicrobial activity of grape seed extracts (Anastasiadi et al., 2009). These observations 317 
raise the question of how the hydroxyl groups (structure) of flavonoids affect oral bacterial 318 
biofilm. 319 
The search for new antimicrobial agents to control the formation of dental plaque requires 320 
appropriate screening models that include orally relevant organisms. The model used in this 321 
study is not only useful for investigating ecological shifts in plaque composition in response to 322 
plaque composition but also for testing the efficacy of antimicrobial agents under conditions of 323 
repeated short-term exposure (Guggenheim et al., 2004). 324 
 325 
Change in wine phenolic metabolism 326 
Because wine and their polyphenols diminished bacteria population in the oral biofilm, a new 327 
assay was performed in order to gain a deeper understanding about microbial metabolism of 328 
polyphenols in the tested extracts.  329 
Firstly, the wine extract solution was added to the growth media and the progress of the 330 
phenolic metabolism by the five-species biofilm was studied by monitoring changes in the 331 
main phenolic compounds present in the wine extract (Table 1), this is to say, flavan-3-ols 332 
monomers ((+)-catechin, (-)-epicatechin and (-)-epicatechin 3-O-gallate, dimeric procyanidins 333 
(B1, B2, B3, B4, B5, B7, B2-3-O-gallate and B2-3-O-gallate), trimeric procyanidins (C1 and 334 
other trimers) and flavonols (quercetin, myricetin, kaempherol, quercetin-3-O glucoside and 335 
quercetin-3-O galactoside)). As a brief example, Figure 3 shows the differences in the 336 
degradation by the five-strain biofilm of three of the analyzed precursors, (+)-catechin, 337 
procyanidin B2 and quercetin, when growing in media enriched with the wine extract solution 338 
(1.6 g/L).  The UPLC-MS  analysis of these three compounds showed high degradation rates, 339 
almost completely during the first 2 h of incubation, in the flavan-3-ol precursors, (+)-Catechin 340 
and Procyanidin B2, probably because of their low concentration in the media which permitted 341 
the bacteria of the biofilm using them as a carbon source. However, no degradation of the 342 
precursor quercetin was observed during the incubation period.  343 
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To gain further knowledge about the metabolism of grape polyphenols, specifically in flavan-344 
3-ols metabolism, the growing media was enriched by adding, to the red wine extract solution, 345 
a concentration of 10 g/L of grape seed extract, which is especially rich in flavan-3-ol 346 
precursors. Despite the greater concentration of flavan-3-ol precursors, no degradation of the 347 
flavan-3-ol precursors was observed, which could be associated with the high concentration of 348 
the studied compounds that, in fact, had an antimicrobial effect on three out of the five bacteria 349 
comprising the biofilm, as demonstrated in the antimicrobial assay (previous section). No 350 
degradation of precursor quercetin was observed during the incubation period.  351 
The emergence of antibiotic resistance by some oral bacteria biofilm species presents a 352 
worldwide problem, and thus novel strategies are required. The use of natural antimicrobials 353 
may contribute to controlling the disordered growth of oral microbiota, thus overcoming 354 
problems caused by species resistant to conventional antimicrobials (Nascimento et al., 2000). 355 
To our knowledge, this is the first report on the antimicrobial properties of wine in an oral 356 
biofilm model. Our results show that red wines, consumed in moderation, inhibit the growth of 357 
some pathogenic species in an oral biofilm model. These findings contribute to existing 358 
knowledge about the beneficial effects of red wines (one of the most important products of 359 
agriculture and food industries) on human health. Moreover, the promising results concerning 360 
grape seed extract, which showed the highest antimicrobial activity, open promising ways 361 
towards a natural ingredient in the formulation of oral care products specifically indicated for 362 
the prevention of caries, due to its antimicrobial properties. 363 
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Table 1. Main phenolic compounds in wine and extracts. 463 
 464 
 Wine  
(mg/L) 
(Muñoz-González et. al., 2013) 
Wine extract  
(mg/g) 
(Sánchez-Patán et al., 2012) 
Grape seed extract 
(mg/g) 
(Sánchez-Patán et al., 2011) 
Benzoic acids    
Gallic acid 27.3±0.2 1.06 ± 0.05 9.11 ± 0.01 
Protocatechuic acid 3.88±0.01 n.a. n.a. 
3-O-Methylgallic acid 1.06±0.06 n.a. n.a. 
4-Hydroxybenzoic acid 0.570±0.008 n.a. n.a. 
Vanillic acid 1.85±0.03 n.a. n.a. 
Syringic acid 2.30±0.13 n.a. n.a. 
Benzoic acid 1.14±0.06 n.a. n.a. 
Salicylic acid 0.215±0.001 n.a. n.a. 
Phenols    
Phloroglucinol 0.326±0.030 n.a. n.a. 
Tyrosol 31.4±1.4 18.9 ± 1.3 n.a. 
Dihidroxiphenylpropan-2-ol 0.303±0.045 n.a. n.a. 
Cinnamic acids    
Caffeic acid 6.97±0.26 n.a. n.a. 
p-Coumaric acid 1.39±0.02 n.a. n.a. 
Ferulic acid 0.217±0.018 n.a. n.a. 
Coutaric acid 8.64±0.01 2.00 ± 0.12 n.a. 
Caftaric acid 4.98±0.33 0.192 ± 0.071 n.a. 
Stilbenes    
Resveratrol 7.12±0.29 0.427 ± 0.020 n.a 
Resveratrol-3-Oglucoside n.a. 9.17 ± 0.17 n.a. 
Flavan-3-ols and others    
(+)-Catechin 51.6±1.7 9.90 ± 0.32 74.6 ± 0.09 
(-)-Epicatechin 34.9±2.9 6.87 ± 0.15 67.7 ± 0.75 
(-)-Epicatechin-3-O-gallate n.a. 0.226 ± 0.018 26.2 ± 0.41 
Procyanidin B1 79.1±0.9 11.1 ± 0.1 61.0 ± 1.42 
Procyanidin B2 44.7±0.6 4.69 ± 0.10 45.1 ± 0.95 
B2-3-O-gallate n.a. 0.0271 ± 0.0106 1.80 ± 0.06 
B2-3’-O-gallate n.a. 0.0258 ± 0.0028 1.61 ± 0.01 
Procyanidin B3 16.0±1.0 1.23 ± 0.02 20.4 ± 0.33 
Procyanidin B4 12.9±0.3 0.827 ± 0.018 15.0 ± 0.13 
Procyanidin B5 2.67±0.01 n.a. n.a. 
Procyanidin B7 5.75±0.15 n.a. n.a. 
Procyanidin C1 14.0±0.4 1.07 ± 0.04 7.07 ± 0.08 
Other trimers 7.96±1.05 1.24 ± 0.09 6.81 ± 0.06 (t2) 
Flavonols    
Quercetin 1.92±0.01 22.4 ± 0.6 n.a. 
Myricetin 0.697±0.028 2.55 ± 0.07 n.a. 
Kaempherol n.d. 0.0366 ± 0.0055 n.a. 
Quercetin-3-O-glucoside n.a. 0.137 ± 0.023 n.a. 
Quercetin-3-O-galactoside n.a. 0.107 ± 0.006 n.a. 
Anthocyanins    
Delphinidin-3-O-glucoside 2.58±0.11 0.568 ± 0.012 n.a. 
Cyanidin-3-O-glucoside 0.761±0.041 0.265 ± 0.010 n.a. 
Petunidin-3-O-glucoside 4.06±0.13 1.47 ± 0.03 n.a. 
Peonidin-3-O-glucoside 18.9±2.0 1.78 ± 0.01 n.a. 
Malvidin-3-O-glucoside 36.7±3.4 9.01 ± 0.50 n.a. 
 465 
*n.d._not detected 466 
*n.a._not analyzed 467 
 468 
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Table 2. Mean (±SD) of Log10CFU values for S. mutans, S. oralis, A.oris, F. nucleatum, V. 470 
dispar after treatments with water, ethanol 12% in water, wine, dealcoholized wine and 0.2% 471 
clorhexidine-gluconate. 472 
 473 
 S.mutans S. oralis F.nucleatum A.oris V.dispar 
Water 8.09±0.09 8.42±0.17 5.90±0.89 8.40±0.32 7.36±0.37 
Ethanol 12% in water 8.01±0.16 8.20±0.37 <1.30±0.00a 8.75±0.64 7.92±0.12 
Wine 7.89±0.07 5.77±0.63a <1.30±0.00a 8.37±0.20 6.94±0.38 
Dealcoholized wine 7.68±0.22 4.79±0.80a <1.30±0.00a 8.24±0.07 7.12±0.88 
Clorhexidine-gluconate 0.2% <1.30±0.00a <1.30±0.00a <1.30±0.00a <1.30±0.00a <1.30±0.00a 
 474 
a Significant differences (Dunnett’s test) in the population in comparison to the negative control 475 
(water).  476 
 477 
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Table 3. Mean (±SD) of Log10CFU values for S. mutans, S. oralis, A.oris, F. nucleatum, V. 479 
dispar after treatments with Provinols™, Provinols™ + Vitaflavan®, Provinols™ + IDY 1 and 480 
Provinols™ + IDY 2. 481 
 482 
 S.mutans S. oralis F.nucleatum A.oris V.dispar 
Water + 2.5% DMSO 8.02±0.05 8.47±0.99 6.77±0.07 8.55±0.07 7.74±0.04 
Provinols™ 8.11±0.08 8.59±0.11 6.54±0.57 8.34±0.39 7.68±0.39 
Provinols™ + Vitaflavan® 7.77±0.18 6.49±0.07a <1.30±0.00a <3.30±0.00a 7.95±0.09 
Provinol™ + IDY 1 8.18±0.03 8.60±0.01 7.13±0.13 8.89±0.02 8.15±0.15 
Provinols™ + IDY 2 8.13±0.07 8.44±0.07 7.14±0.04 8.68±0.03 8.11±0.11 
 483 
a Significant differences (Dunnett’s test) in the population in comparison to the negative control 484 
(water + 2.5% DMSO).  485 
 486 
 487 
 488 
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 490 
FIGURE LEGENDS 491 
Figure 1. Biofilm formation/maturation and assays diagram 492 
Figure 2. Confocal scanned segment of biofilm stained with LIVE/DEAD kit after exposure to 493 
(A) negative control (water), (B) wine extract (Provinols™, 1.6 g/L), (C) red wine, and (D) 494 
grape seed extract (Vitaflavan®,  2.5 g/L) in wine extract solution (1.6 mg/mL). 495 
Figure 3.  Metabolism of precursors (+)-Catechin, Quercetin and Procyanidine B2 after 496 
0,2,4,6 8 and 24 hours of incubation in FUM media enriched with (A) Provinols™ and (B) 497 
Vitaflavan® 1% in Provinols™ solution.  498 
499 
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FIGURES  500 
 501 
 502 
Figure 1. Biofilm formation/maturation and assays diagram. 503 
504 
Saliva
(Soft shaking)
Phenolic metabolism in the biofilm
Saliva pellicle formation Biofilm formation Assays performance
5-species 
mix
Saliva:FUM; 70:30
Saliva:modified FUM; 70:30
+ wine or grape seed extracts
Supernatant collection 
at 0, 2, 4, 6, 8 & 24h+
O2
4h
RT
O2
45min
37ºC
Biofilm maturation
Saliva
UPLC-MS analysis
Changes in the microbial population of the biofilm
“Feeding”
Saliva:modified FUM; 70:30
“Dipping”
Test solutions
+ 
O2
16.5h
37ºC
37ºC
O2
7days
X2
45min
37ºC
O2
23 
 
 505 
Figure 2. Confocal scanned segment of biofilm stained with LIVE/DEAD kit after exposure to 506 
(A) negative control (water), (B) wine extract (Provinols™, 1.6 g/L), (C) red wine, and (D) 507 
grape seed extract (Vitaflavan®, 2.5 g/L) in wine extract solution (1.6 mg/mL). 508 
  509 
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 517 
Figure 3.  Metabolism of precursors (+)-Catechin, Quercetin and Procyanidine B2 after 518 
0,2,4,6 8 and 24 hours of incubation in FUM media enriched with (A) Provinols™ and (B) 519 
Vitaflavan® 1% in Provinols™ solution.  520 
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